The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization

被引：38

作者：

Zou, Jing ^{[1
]}

Xie, Xuping ^{[1
]}

Fontes-Garfias, Camila R. ^{[1
]}

Swanson, Kena A. ^{[2
]}

Kanevsky, Isis ^{[2
]}

Tompkins, Kristin ^{[2
]}

Cutler, Mark ^{[2
]}

Cooper, David ^{[2
]}

Dormitzer, Philip R. ^{[2
]}

Shi, Pei-Yong ^{[1
,3
,4
,5
]}

机构：

[1] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA

[2] Pfizer, Pearl River, NY 10965 USA

[3] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA

[4] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA

[5] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA

来源：

NPJ VACCINES | 2021年 / 6卷 / 01期

关键词：

D O I：

10.1038/s41541-021-00313-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Initial COVID-19 vaccine candidates were based on the original sequence of SARS-CoV-2. However, the virus has since accumulated mutations, among which the spike D614G is dominant in circulating virus, raising questions about potential virus escape from vaccine-elicited immunity. Here, we report that the D614G mutation modestly reduced (1.7-2.4-fold) SARS-CoV-2 neutralization by BNT162b2 vaccine-elicited mouse, rhesus, and human sera, concurring with the 95% vaccine efficacy observed in clinical trial.

引用

页数：4

共 50 条

[21] D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
Weissman, Drew
Alameh, Mohamad-Gabriel
de Silva, Thushan
Collini, Paul
Hornsby, Hailey
Brown, Rebecca
LaBranche, Celia C.
Edwards, Robert J.
Sutherland, Laura
Santra, Sampa
Mansouri, Katayoun
Gobeil, Sophie
McDanal, Charlene
Pardi, Norbert
Hengartner, Nick
Lin, Paulo J. C.
Tam, Ying
Shaw, Pamela A.
Lewis, Mark G.
Boesler, Carsten
Sahin, Ugur
Acharya, Priyamvada
Haynes, Barton F.
Korber, Bette
Montefiori, David C.
CELL HOST & MICROBE, 2021, 29 (01) : 23 - +
[22] D614G and SARS-CoV-2 replication fitness
Kathleen D. Engelman
Alan N. Engelman
Signal Transduction and Targeted Therapy, 6
[23] Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xie, Xuping
Liu, Yang
Liu, Jianying
Zhang, Xianwen
Zou, Jing
Fontes-Garfias, Camila R.
Xia, Hongjie
Swanson, Kena A.
Cutler, Mark
Cooper, David
Menachery, Vineet D.
Weaver, Scott C.
Dormitzer, Philip R.
Shi, Pei-Yong
NATURE MEDICINE, 2021, 27 (04) : 620 - 621
[24] D614G and SARS-CoV-2 replication fitness
Engelman, Kathleen D.
Engelman, Alan N.
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
[25] Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients
Yanay, Noa Berar
Freiman, Sarit
Shapira, Ma'anit
Wishahi, Samar
Hamze, Munir
Elhaj, Mohamad
Zaher, Maha
Armaly, Zaher
KIDNEY INTERNATIONAL, 2021, 99 (06) : 1496 - 1498
[26] Herpes zoster infection following SARS-CoV-2 vaccine BNT162b2
Lauro, Wanda
Cillo, Francesco
Nastro, Francesca
Fabbrocini, Gabriella
Marasca, Claudio
ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2023, 158 (04) : 364 - 365
[27] Structural effects of spike protein D614G mutation in SARS-CoV-2
Dokainish, Hisham M.
Sugita, Yuji
BIOPHYSICAL JOURNAL, 2023, 122 (14) : 2910 - 2920
[28] Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2
Tomer Hertz
Shlomia Levy
Daniel Ostrovsky
Hanna Oppenheimer
Shosh Zismanov
Alona Kuzmina
Lilach M. Friedman
Sanja Trifkovic
David Brice
Lin Chun-Yang
Liel Cohen-Lavi
Yonat Shemer-Avni
Merav Cohen-Lahav
Doron Amichay
Ayelet Keren-Naus
Olga Voloshin
Gabriel Weber
Ronza Najjar-Debbiny
Bibiana Chazan
Maureen A. McGargill
Richard Webby
Michal Chowers
Lena Novack
Victor Novack
Ran Taube
Lior Nesher
Orly Weinstein
Nature Communications, 14
[29] Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie
Yang Liu
Jianying Liu
Xianwen Zhang
Jing Zou
Camila R. Fontes-Garfias
Hongjie Xia
Kena A. Swanson
Mark Cutler
David Cooper
Vineet D. Menachery
Scott C. Weaver
Philip R. Dormitzer
Pei-Yong Shi
Nature Medicine, 2021, 27 : 620 - 621
[30] Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2
Hertz, Tomer
Levy, Shlomia
Ostrovsky, Daniel
Oppenheimer, Hanna
Zismanov, Shosh
Kuzmina, Alona
Friedman, Lilach M.
Trifkovic, Sanja
Brice, David
Chun-Yang, Lin
Cohen-Lavi, Liel
Shemer-Avni, Yonat
Cohen-Lahav, Merav
Amichay, Doron
Keren-Naus, Ayelet
Voloshin, Olga
Weber, Gabriel
Najjar-Debbiny, Ronza
Chazan, Bibiana
McGargill, Maureen A.
Webby, Richard
Chowers, Michal
Novack, Lena
Novack, Victor
Taube, Ran
Nesher, Lior
Weinstein, Orly
NATURE COMMUNICATIONS, 2023, 14 (01)

← 1 2 3 4 5 →